Skip to main content
Toggle navigation
Login
Search
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
I
Icten, Zeynep
Panalgo
PP-01F - Predictors of Severe COVID-19 Outcome in Patients with Rheumatoid Arthritis
Location:PP-01
Zeynep Icten
Favorite
SP09C - Factors Associated with Initiation of Oral vs. Injectable Disease Modifying Therapies Among Multiple Sclerosis Patients: A Machine Learning Approach
Location:SP09
Zeynep Icten
Favorite
Igland, Jannicke
BIOS. Department of Global Public Health and Primary Care, University of Bergen
OP-21A - Prenatal Antiseizure Medication Exposure and Risk of Autism and Intellectual Disability. SCAN-AED: A Nordic Cohort Study
Location:OP-21
Jannicke Igland
Favorite
Im, Theresa
Research and Evaluation, Kaiser Permanente Southern California
OP-2F - Validation of an Algorithm to Identify Hormonal Contraceptive Exposure in a Large Integrated Health Care Delivery System Database
Location:OP-02
Theresa Im
Favorite
Incerti, Devin
Genentech
WS-17 - Selection Matters: Addressing Biases in Linked Clinico-genomic Data Sets
Location:WS-17
Devin Incerti
Favorite
Inglesby, Peter
University of Oxford
OP-27C - Shifting the Traditional Model of Analysing Downloaded Electronic Health Records to the Novel Open-source Analytics Opensafely Platform
Location:OP-27
Peter Inglesby
Favorite
PP-01C - Ethnic Differences in COVID-19 Infection, Hospitalisation, and Mortality: An Opensafely Analysis of 17 Million Adults in England
Location:PP-01
Peter Inglesby
Favorite
Investigators, OBRI
Toronto Genral Hospital Research Institute, University Health Network, Toronto.ON
OP-6D - Discontinuation Rate of Tofacitinib Is Similar When Compared to TNF Inhibitors in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Cohort
Location:OP-06
OBRI Investigators
Favorite
OP-12F - Physician and Patient Reported Effectiveness Outcomes Are Similar in Tofacitinib and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Registry in Canada
Location:OP-12
OBRI Investigators
Favorite
Ip PhD, Patrick
Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong
SP15C - Treatment for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of Poisoning in Children and Adolescents
Location:SP15
Patrick Ip PhD
Favorite
Irwin, Debra
IBM Watson Health
L-3F - Distinguishing Death from Disenrollment in Claims Data Using a Readily Implemented Machine Learning Algorithm
Location:L-3
Debra Irwin
Favorite
SP13F - EXOGEN Mitigates Risk of Fifth Metatarsal Fracture Nonunion: Results of a Novel Real-world Clinical Study
Location:SP13
Debra Irwin
Favorite
Isherwood, Tara
Syneos Health
SP11E - FDA regulatory routes and clinical post-marketing requirements for personalized medicines
Location:SP11
Tara Isherwood
Favorite
Iskandar, Ireny
Centre for Occupational and Environmental Health, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester
OP-19C - Fertility Rates in Women with Psoriasis and Psoriatic Arthritis: A Population-based Cohort Study
Location:OP-19
Ireny Iskandar
Favorite
Iyasu, Solomon
Merck & Co., Inc.
WS-03 - Big Data in Health and Bioethics: A Call for a Comprehensive, Multi-disciplinary, ISPE Position
Location:WS-03
Solomon Iyasu
Favorite
Izano, Monika
Syapse
OP-12C - The Friends of Cancer Research Real World Data (RWD) Pilot 2.0 Collaboration: Implementation of Standardized Methodological Approaches for Evaluation of Oncology RWD
Location:OP-12
Monika Izano
Favorite
